1.05k likes | 1.36k Views
Nephrology Mini-Symposium: Acute Cardiorenal Syndrome. R3 潘思宇 ,R3 李宗育 ,R3 張凱迪 ,R3 柯雅琳 R5 王介立 /VS 林水龍 Nov. 24 th , 2010. “Cardiorenal” for 100 Years. Sir Thomas Lewis (1881-1945). Lewis T., Br Med J 1913;2:1417-20. PubMed Trend. NIH Definition. Ronco Classification.
E N D
Nephrology Mini-Symposium:Acute Cardiorenal Syndrome R3潘思宇,R3李宗育,R3張凱迪,R3柯雅琳 R5王介立/VS林水龍 Nov. 24th, 2010
“Cardiorenal” for 100 Years • Sir Thomas Lewis (1881-1945) Lewis T., Br Med J 1913;2:1417-20
PubMed Trend NIHDefinition Ronco Classification
Working Definition (2004) At its extreme, cardio-renal dysregulation leads to what is termed “cardio-renal syndrome” in whichtherapy to relieve congestive symptoms of heart failure is limited by further decline in renal function. It is clear that our current understanding of cardio-renal connections is inadequate to explain many of the clinical observations in heart failure or to direct its therapy. NHLBI Working Group. http://www.nhlbi.nih.gov/meetings/workshops/cardiorenal-hf-hd.htm
Proposed Classification (2008) Acute Chronic HeartKidney (cardiorenal) KidneyHeart (renocardiac) Ronco C. et al. J Am CollCardiol 2008;52:1527-39.
Cardiorenal Syndrome is Always There Type 2 and 4 Type 3
This year, 2010, we present you the… Type 1 Cardiorenal Syndrome Acute decompensated heart failure Acute myocardial infarction Low cardiac output syndrome post cardiac surgery
CASE PRESENTATION There’s Always a Problem…
Acute Cardiorenal Syndrome Epidemiology & Pathophysiology. R3 潘思宇 Diagnosis & Management......…... R3 李宗育 Volume & Diuretics………………. R3 張凱迪 Ultrafiltration………………………. R3 柯雅琳 R5 王介立 VS 林水龍
Cardiorenal Syndrome Type I • Acute heart disorder leading to acute kidney injury • Acute heart disorder ? • Acute decompensated heart failure • Acute coronary syndrome • (Low cardiac output syndrome after open heart surgery) • Acute kidney injury ? • ARF, Worsening renal function • AKI: RIFLE, AKIN, K-DIGO • Biomarkers: NGAL, cystatin C
Epidemiology Acute decompensated heart failure Acute coronary syndrome
Observational, 2002/10~2004/10, France WRF:↑Cre > 0.3 mg/dL, Total: 416 with AHF WRF: 37% D. Logeart et al, Int J Cardiol2008; 127: 228–232
Event: death or unscheduled readmission for HF P = 0.01 D. Logeart et al, Int J Cardiol2008; 127: 228–232
Observational, 1994/1~1996/2, Total: 147007 with AMI Mild: ↑0.3~0.4, Mod: ↑0.5~0.9, Severe: ↑≧1.0 mg/dL 7.1% 7.1% 5.2% CR Parikh et al, Arch Intern Med. 2008;168(9):987-995
Observational, 1994/1~1996/2, Total: 147007 with AMI Mild: ↑0.3~0.4, Mod: ↑0.5~0.9, Severe: ↑≧1.0 mg/dL P < 0.01 At all time points 1 yr 3 yr 10 yr 5 yr CR Parikh et al, Arch Intern Med. 2008;168(9):987-995
Pathophysiology The low flow state hypothesis Venous congestion: IAP & CVP Others: Neurohormonal activation
Pgc: Glomerular pressure, PT : Tubular pressure πgc: Glomerular colloid p, πT: Tubular colloid p △π Pgc PT GFR α( Pgc- PT -△π) JG Abuelo et al, N Engl J Med 2007; 357(8): 797-805
Pgc • MAP? • Intra-Abdominal hypertension? • Change of Resistance at A or E arteriole? • PT • Intra-Abdominal hypertension? • Tubular obstruction? Pgcα (MAP – IAP) MAPαPgc αGRF Factors affect GFR
Franklin H. Epstein et al, N Engl J Med1999; 341(8): 577-585
If this low output theory holds true, then … ? ↓LVEF / CI ↓GFR ↓Renal perfusion 灌水 Dopamine!!! 這病人 Kidney 不好
Prospective, 1990, USA, CHF, Total: 34 A: CI>2 ; B: CI 1.5~2 ; C: CI <1.5 L/min/m2 Autoregulation Ljungman et al. Drugs 1990; 39(Suppl. 4): 10-21
Renal auto-regulation Brenner and Rector’s The Kidney, 8th ed http://www2.kumc.edu/ki/physiology/course/two/2_4.htm
Pgc • MAP? • Intra-Abdominal hypertension? • Change of Resistance at A or E arteriole? • PT • Intra-Abdominal hypertension? • Tubular obstruction? Pgcα (MAP – IAP) Factors affect GFR PTαIAP
IAP range in critical care • Normal: 5-7 mmHg • Elevated: ≥8 mmHg • IAH: ≥ 12mmHg Wilfried Mullens et at, Intensive Care Med (2006) 32:1722–1732
Prospective cohort, 2006/11~2007/5, CCU, USA AHF: LVEF<30%, PCWP>18 or CVP>8, Total: 40 Goal: PCWP<18, CVP<8, CI>2.2 Wilfried Mullens et at, Intensive Care Med (2006) 32:1722–1732
Retrospective cohort, 1989/1~2006/12, CCU, Netherland Patient s/p Rt heart catheterization, Total: 2557 Baseline CVP vs. GFR Kevin Damman et al., J Am Coll Cardiol 2009; 53(7): 582–8
Prospective, 2006/1~2007/6, USA, CCU, Total: 145 Inclusion: LVEF<30%, CI<2.4, PCWP>18 or CVP>8 PA catheter goal: PCWP<18, CVP<8, & CI>2.4 CVP rather than CI ? WilfriedMullens et al, J Am CollCardiol 2009; 53(7)589–96
Animal study, Dog, 1931, Renal a & v cannulation F. R. Winton et al, J Physiol 1931; 72: 49–61.
Fluid status evaluation in CRS ? Venous congestion may be more important than hypovolemia 灌水 脫水
Other postulated mechanisms of CRS • Low evidence & inconclusive • Sympathetic overactivity • Adenosine • Vasopressin • Natriuretic peptide • Oxidative injury & endothelial dysfunction Jeremy S. Bock et al, Circulation. 2010;121:2592-2600.
Animal study, Rat, 1980, Renal sympathetic stimulate, Total: 10 Gerald F. Dibona et al, Physiol Rev, 1997; 77(1): 75-197
Prospective cohort, 2007/6~2008/11, Australia & European Hypertension s/p renal sympathetic denervation, Total: 45 ? Improvement of hypertension Improvement of renal function Henry Krum et al, Lancet 2009; 373: 1275–81
老師, 第三床 ARF咧 要不要作 Renal biopsy看一看? 第三床不是 Heart failure嗎? 阿就是Pre-renal ARF阿, Biopsy做什麼?
Pathology • Acute heart failure not a traditional indication for renal biopsy • Case report • The characteristics of acute renal failure in cardiogenic shock in the elderly • 4 patients with cardiogenic shock and ARF • 1 patient with ATN • 3 patients without pathological change Durakovi et al, ZFA 1986; 41(5): 301-5
Can we predict who will developed CRS in patients presented with acute cardiac dysfunction?
Known Predictors from Past Observations (I) WH Tang & W. Mullens. Heart. 2010; 96(4):255-60
Known Predictors from Past Observations (II) WH Tang & W. Mullens. Heart. 2010; 96(4):255-60
Summary • AKI occurs frequently in AHF (type 1 CRS) • It is an independent risk factor of worse outcome • However, only very limited prospective observational studies have addressed the issues • The mechanism of type 1 CRS remained largely speculative • We have no ideas why his (her) kidney failed • Venous congestion should be kept in mind other than arterial underfilling
Acute Cardiorenal Syndrome Epidemiology & Pathophysiology. R3 潘思宇 Diagnosis & Management......…... R3 李宗育 Volume & Diuretics………………. R3 張凱迪 Ultrafiltration………………………. R3 柯雅琳 R5 王介立 VS 林水龍
CASE PRESENTATION Back to the Problem… How do we know the sequence?
CASE PRESENTATION Time Course of the eGFR CKD stage 3 AKI Acute (type 1,3) rather than chronic (type 2,4)…
CASE PRESENTATION Cause of CKD? 12 cm (Long-standing; microscopicovert) Other non-DM cause of CKD related to CVD: - Ischemic nephropathy (renovascular disease) - Malignant hypertension
CASE PRESENTATION AKIfrom Heart? Hypotensive episode? “No diagnostic criteria = by exclusion”
Typical Acute CRS • Acute heart failure syndrome • Acute kidney injury • No evidence of intrinsic kidney disease other than the baseline CKD So far, has the diagnosis of type 1 cardiorenal syndrome been secured?
Mimickers of Type 1 CRS • NSAIDs causing concurrent heart failure and vasomotor nephropathy • Flash pulmonary edema (bilateral renal artery stenosis) • Hypertensive crisis from identifiable causes (e.g. pheochromocytoma) (the primary cause is outside the heart) (potentially treatable)